About Spectrumedics
Spectrumedics is a Healthcare company based in Singapore (Singapore) founded in 2018 by Peng Huiqun, Al Ray Tabiliran, and Elynn Phang. Spectrumedics has raised $14.99 million across 1 funding round from investors including Legend Capital, BC Capital and Yangyun Capital. Its chief executive is Elynn Phang. Spectrumedics offers products and services including Targeted Treatment Device. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is SPECTRUMEDICS INTERNATIONAL PTE. LTD. Its competitors include Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Shenzhen Hannuo Medical Technology and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification. The company has developed a product named Sonico- an intravascular shock wave balloon catheter system for treating arterial vascular calcification using shock wave therapy.
- Headquarters Singapore, Singapore
- Founders Peng Huiqun, Al Ray Tabiliran, Elynn Phang
- SectorsHealthcare
- Website spectrumedics.com
- Social LinkedIn
- Legal Name Spectrumedics International Pte. Ltd.
- Annual Revenue$152.11 K (USD)183as on Dec 31, 2023
- Net Profit-$576.04 K (USD)19as on Dec 31, 2023
- EBITDA-$576.04 K (USD)19as on Dec 31, 2023
- Total Equity Funding$14.99M (USD)
in 1 rounds
- Latest Funding Round$14.99M (USD), Series A
May 2022
- InvestorsLegend Capital
& 3 more
Products & Services of Spectrumedics
Spectrumedics offers a comprehensive portfolio of products and services, including Targeted Treatment Device.
Device for seamless and precise medical treatments
Funding Insights of Spectrumedics
Spectrumedics has successfully raised a total of $14.99M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.99 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.99M
- Total Rounds 1
- Last Round Series A — $14.99M
- First Round $14.99M
(May 2022)
- Investors Count 4
All 1 funding rounds of Spectrumedics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $14.99M | Series A | – | Legend Capital |
4 investors in total: 4 institutional.
Investors in Spectrumedics
Spectrumedics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Legend Capital, BC Capital and Yangyun Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture Capital firm focused on multiple sectors | – | legendcapital.com.cn | Haidian, China | |
- | – | yang-yun.com | - | |
- | – | wildercapital.tcc.mode | - | |
Limited information is provided about BC Capital's activities. | – | bccapital.com | - |
Investor details for Spectrumedics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Spectrumedics
3 people are tracked at Spectrumedics (3 in leadership).
| Name | Role | Group |
|---|---|---|
Peng Huiqun | Co-Founder | Leadership |
Al Ray Tabiliran | Co-Founder & CTO | Leadership |
Elynn Phang | Co-Founder & CEO | Leadership |
Complete people profiles for Spectrumedics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Spectrumedics
2 dated milestones of Spectrumedics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Spectrumedics is founded.
- Funding First funding round of $15.0M.
Competitors of Spectrumedics
Spectrumedics has 9 listed competitors in our database, 6 of them funded. They include Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| orchestrabiomed.com | 2017 | New Hope, United States | $205.88M | – | Medical devices for hypertension and atherosclerosis treatment are developed. | |
| biotronik.com | 1963 | Berlin, Germany | – | 1,196 | Cardiovascular products and equipment are developed, manufactured, and distributed. | |
| inquismedical.com | 2019 | Redwood, United States | $40M | – | Developer of medical device for the treatment of peripheral thrombectomy | |
| synapticmed.com | 2005 | Lake Forest, United States | $60M | – | Medical devices for cardiac arrhythmias and cardiovascular diseases are developed. | |
| cbmed.cn | 2018 | Shenzhen, China | $14.04M | – | Extracorporeal circulation products including ECMO are developed for medical support. | |
| techbankcapital.com | 2015 | Shanghai, China | $14.93M | – | Medical devices for cardiac disease treatment are developed. | |
| scientechmed.com | 2021 | Shanghai, China | – | – | Medical devices for cardiovascular diseases are developed. | |
| med-zenith.com | 2005 | Beijing, China | – | – | Electrosurgical devices for cardiovascular treatments are manufactured. | |
| pulsemed.cn | 2012 | Zhuhai, China | $1.45M | – | Cardiovascular medical devices are developed and manufactured in China. |
Detailed competitors of Spectrumedics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Spectrumedics (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spectrumedics
Spectrumedics was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Spectrumedics is headquartered in Singapore, Singapore.
Elynn Phang is the current CEO of Spectrumedics. They have also founded this company.
Spectrumedics is a funded company, having raised a total of $14.99M across 1 funding round to date. The company's 1st funding round was a Series A of $14.99M, raised on May 2022.
Annual revenue of Spectrumedics is $152.11K as on Dec 31, 2023.
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification. The company has developed a product named Sonico- an intravascular shock wave balloon catheter system for treating arterial vascular calcification using shock wave therapy.
Spectrumedics's top competitors include Orchestra BioMed, Biotronik and Inquis Medical.
Spectrumedics offers Targeted Treatment Device.
Spectrumedics has 4 investors. Key investors include Legend Capital, BC Capital, Yangyun Capital, and Wilder Capital.
Spectrumedics operates through Spectrumedics International Pte. Ltd..